Slice is a fixed effect controlling for the position within the lung from which the sample core was obtained
Both are stable in bacteriostatic water and do not interact chemically
Participants were randomized to receive once-weekly subcutaneous injections of eloralintide at doses of 1 mg, 3 mg, 6 mg, or 9 mg, or dose escalation regimens of 39 mg or 69 mg, or placebo
The peptide BPC-157 has not been evaluated for safety as part of the drug review process of the United States Food and Drug Administration (FDA), nor has it been formally evaluated for safety by any international regulatory counterpart of the FDA
Furthermore, the peptide increased the frequency of acrocentric chromosome associations, reflecting elevated transcriptional and synthetic activity
These vendors sell BPC-157 as a research compound not intended for human consumption